Carboplatin Inhibits the Progression of Retinoblastoma Through IncRNA XIST/miR-200a-3p/NRP1 Axis

References

• Xiao J, Ma M, Liang Ming, et al. [Site-directed mutagenesis of long gene by partial amplification combining with double fragments ligation]. Sheng Wu Gong Cheng Xue Bao 2020;36:1232–1240.
   Google Scholar
• GolabchiK, Soleimani-JelodarR, AghadoostN, et al. MicroRNAs in retinoblastoma: potential diagnostic and therapeutic biomarkers. J Cell Physiol. 2018;233(4):3016–3023. doi:10.1002/jcp.2607028657205
   PubMed Web of Science ®Google Scholar
• Singh L, Singh MK, Rizvi MA, et al. Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma. Cancer Immunol. Immunother 2020;69:1087–1099.
   Google Scholar
• Jiménez I, Laé M, Tanguy M, et al. Craniofacial second primary tumors in patients with germline retinoblastoma previously treated with external beam radiotherapy: A retrospective institutional analysis. Pediatr Blood Cancer. 2020;67:e28158.
   Google Scholar
• DamatoB, AfsharAR, EverettL, et al. The University of California, San Francisco documentation system for retinoblastoma: preparing to improve staging methods for this disease. Ocul Oncol Pathol. 2019;5(1):36–45. doi:10.1159/00048814730675475
   PubMed Web of Science ®Google Scholar
• ThomasNA, AbrahamRG, DediB, et al. Targeting retinoblastoma protein phosphorylation in combination with EGFR inhibition in pancreatic cancer cells. Int J Oncol. 2019;54(2):527–536. doi:10.3892/ijo.2018.465830535494
   PubMed Web of Science ®Google Scholar
• Cruz-GalvezCC, Ortiz-LazarenoPC, Pedraza-BrindisEJ, et al. Pentoxifylline enhances the apoptotic effect of carboplatin in Y79 Retinoblastoma Cells. In Vivo. 2019;33(2):401–412. doi:10.21873/invivo.1148730804118
   PubMed Web of Science ®Google Scholar
• Soliman SE, D'Silva CrN, Dimaras H, et al. Clinical and genetic associations for carboplatin-related ototoxicity in children treated for retinoblastoma: A retrospective noncomparative single-institute experience. Pediatr Blood Cancer 2018;65:e26931.
   Google Scholar
• NikpayamE, TasharrofiB, SarrafzadehS, et al. The role of long non-coding RNAs in ovarian cancer. Iran Biomed J. 2017;21(1):3. doi:10.18869/acadpub.ibj.21.1.327664137
   PubMedGoogle Scholar
• ZhangD, SunX, ZhangY. Downregulation of LncRNA PMS2L2 in endometrial adenocarcinoma upon carboplatin treatment. Cancer Manag Res. 2019;11:8905. doi:10.2147/CMAR.S22127431632150
   PubMed Web of Science ®Google Scholar
• ChengY, ChangQ, ZhengB, et al. LncRNA XIST promotes the epithelial to mesenchymal transition of retinoblastoma via sponging miR-101. Eur J Pharmacol. 2019;843:210–216. doi:10.1016/j.ejphar.2018.11.02830472203
   PubMed Web of Science ®Google Scholar
• WeiW, LiuY, LuY, et al. LncRNA XIST promotes pancreatic cancer proliferation through miR-133a/EGFR. J Cell Biochem. 2017;118(10):3349–3358. doi:10.1002/jcb.2598828295543
   PubMed Web of Science ®Google Scholar
• TangY, HeR, AnJ, et al. lncRNA XIST interacts with miR-140 to modulate lung cancer growth by targeting iASPP. Oncol Rep. 2017;38(2):941–948. doi:10.3892/or.2017.575128656261
   PubMed Web of Science ®Google Scholar
• ChenD, ChenL, LuY, et al. Long noncoding RNA XIST expedites metastasis and modulates epithelial–mesenchymal transition in colorectal cancer. Cell Death Dis. 2017;8(8):e3011. doi:10.1038/cddis.2017.42128837144
   PubMed Web of Science ®Google Scholar
• ZhouS, WangL, YangQ, et al. Systematical analysis of lncRNA–mRNA competing endogenous RNA network in breast cancer subtypes. Breast Cancer Res Treat. 2018;169(2):267–275. doi:10.1007/s10549-018-4678-129388017
   PubMed Web of Science ®Google Scholar
• KönigsrainerA, RauB. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): don’t throw the baby out with the bathwater. Pleura Peritoneum. 2018;3(4). doi:10.1515/pp-2018-0131
   Web of Science ®Google Scholar
• Biasini A, Smith AAT, Abdulkarim B, et al. The Contribution of lincRNAs at the Interface between Cell Cycle Regulation and Cell State Maintenance. iScience 2020;23:101291.
   Google Scholar
• LvL, WeiM, LinP, et al. Integrated mRNA and lncRNA expression profiling for exploring metastatic biomarkers of human intrahepatic cholangiocarcinoma. Am J Cancer Res. 2017;7(3):688.28401021
   PubMed Web of Science ®Google Scholar
• YangC, WuK, WangS, et al. Long non‐coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR‐195‐5p. J Cell Biochem. 2018;119(7):5646–5656. doi:10.1002/jcb.2674329384226
   PubMed Web of Science ®Google Scholar
• LinX, HuangZ, ChenX, et al. XIST induced by JPX suppresses hepatocellular carcinoma by sponging miR-155-5p. Yonsei Med J. 2018;59(7):816–826. doi:10.3349/ymj.2018.59.7.81630091314
   PubMed Web of Science ®Google Scholar
• ShiJ, TanS, SongL, et al. LncRNA XIST knockdown suppresses the malignancy of human nasopharyngeal carcinoma through XIST/miRNA-148a-3p/ADAM17 pathway in vitro and in vivo. Biomed Pharmacother. 2020;121:109620. doi:10.1016/j.biopha.2019.10962031810117
   PubMed Web of Science ®Google Scholar
• LiSP, XuHX, YuY, et al. LncRNA HULC enhances epithelial-mesenchymal transition to promote tumorigenesis and metastasis of hepatocellular carcinoma via the miR-200a-3p/ZEB1 signaling pathway. Oncotarget. 2016;7(27):42431. doi:10.18632/oncotarget.988327285757
   PubMed Web of Science ®Google Scholar
• SunR, ZhangL. Long non-coding RNA MALAT1 regulates cardiomyocytes apoptosis after hypoxia/reperfusion injury via modulating miR-200a-3p/PDCD4 axis. Biomed Pharmacother. 2019;111:1036–1045. doi:10.1016/j.biopha.2018.12.12230841417
   PubMed Web of Science ®Google Scholar
• AviorY, LezmiE, YanukaD, et al. Modeling developmental and tumorigenic aspects of trilateral retinoblastoma via human embryonic stem cells. Stem Cell Rep. 2017;8(5):1354–1365. doi:10.1016/j.stemcr.2017.03.005
   PubMed Web of Science ®Google Scholar
• EggerJV, LaneMV, AntonucciLA, et al. Dephosphorylation of the retinoblastoma protein (Rb) inhibits cancer cell EMT via Zeb. Cancer Biol Ther. 2016;17(11):1197–1205. doi:10.1080/15384047.2016.123566827645778
   PubMed Web of Science ®Google Scholar
• ZhuX, XueL, YaoY, et al. The FoxM1-ABCC4 axis mediates carboplatin resistance in human retinoblastoma Y-79 cells. Acta Biochim Biophys Sin (Shanghai). 2018;50(9):914–920. doi:10.1093/abbs/gmy08030060118
   PubMed Web of Science ®Google Scholar